Showing results (101-110 of 266) with videos related to
Sort By:
Pageof 27
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 9, 2020
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature reviewMartina Sanlorenzo, Simone Ribero, Simona Osella Abate, et al.Dermatitis : Contact, Atopic, Occupational, Drug|July 22, 2024
Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis®: Clinical Effectiveness in Real LifeLuca Mastorino, Richard Borrelli, Nicole Macagno, et al.Melanoma Research|October 26, 2021
Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lessonMichele Parietti, Elena Marra, Simone Ribero, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 5, 2023
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatmentLuca Mastorino, Paolo Dapavo, Sara Susca, et al.Frontiers in Pharmacology|March 23, 2026
Effectiveness and safety of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaGabriele Roccuzzo, Eleonora Bongiovanni, Giovanni Actis-Giorgetto, et al.Tropical Medicine & International Health : TM & IH|July 1, 2024
A noma case report: A warning message from Northern UgandaBianca Maria Longo, Martina Merli, Bonny Achana, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2024
Alcohol abuse and discretionary habits in psoriatic patients: impact on IL-17 and IL-23 inhibitors responseLuca Mastorino, Rebecca Daniele, Paolo Dapavo, et al.Journal of Clinical Medicine|April 3, 2021
Oral Manifestations in Melanoma Patients Treated with Target or Immunomodulatory TherapiesEmi Dika, Martina Lambertini, Bruna Gouveia, et al.Experimental Dermatology|March 1, 2023
Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 yearsMarco Miniotti, Simone Ribero, Luca Mastorino, et al.JHLT Open|December 1, 2025
The burden of skin cancer in heart transplant recipients: Impact of immunosuppressive regimensMatteo Marro, Gabriele Roccuzzo, Erika Simonato, et al.Pageof 27